Literature DB >> 3316399

Purification of human autoantibodies from cross-linked antigen immunosorbents.

A C Horsfall1, C M Brown, R N Maini.   

Abstract

A method is described whereby autoantibodies to the Sjögren's syndrome antigen La (SS-B) can be purified from re-usable immunosorbent columns constructed from covalently linked human autoantibodies to which the antigen is cross-linked. Previous attempts to link the antigen directly to CNBr-Sepharose beads resulted in loss of biological activity and thus each purification of antibody required fresh batches of antigen. The present technique is a significant improvement since the cross-linked immunosorbents prepared from a single batch of antigen can be re-used several times over a 6 month period. Furthermore F(ab')2 fragments of anti-La antibodies can be purified from pepsin-digested serum samples. These antibodies react in ELISA, Western blot and immunofluorescence in an identical way to serum and murine monoclonal anti-La antibodies and show no reaction with the Ro antigen. However, being of human origin the affinity-purified anti-La antibodies have the advantages of bearing the same idiotypes and reacting with the same antigenic epitopes as naturally occurring serum autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316399     DOI: 10.1016/0022-1759(87)90485-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity.

Authors:  C Baboonian; P J Venables; J Booth; D G Williams; L M Roffe; R N Maini
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

2.  Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin--a role in the pathogenesis of congenital heart block?

Authors:  J M Li; A C Horsfall; R N Maini
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.